すべての記事|article|すべての記事|NADサルベージ経路、肥満

すべての記事

家
すべての記事

Health Food Expo, Ingredients and Contract Manufacture 2024 is approaching

2024年4月19日

健康食品EXPO・原料・受託製造2024が近づいてきました

On April 24th-25th 2024, Health Food Expo, Ingredients and Contract Manufacture 2024 will be held in Tokyo International Exhibition Hall, Japan. Dr Cheung, the chief scientist and founder of BONTAC, is invi

Potential Treatment for Glaucoma: NAD+ Precursor NR

2024年4月16日

緑内障の潜在的な治療法:NAD +前駆体NR

Introduction Glaucoma is regarded as the second dominant cause of blindness across the world. With the amounting number and proportion of elderly people, it is estimated that 111.8 million people will have glaucom

Mitigation of TOCP-induced Oocyte Damage by Replenishing NMN

2024年4月13日

NMN補充によるTOCP誘発性卵母細胞損傷の軽減

Introduction Triocresyl phosphate (TOCP) is widely used in the realm of industry and agriculture in the last century. However, it is subsequently banned due to the increasing understanding of its toxicity. In

Tight Connection of NADP+/NADPH Balance with Cardiovascular Pathologies

2024年4月12日

NADP+/NADPHバランスと心血管疾患の密接な関係

Introduction Cardiovascular diseases (CVD) poses huge economic burden and great threat to the life of patients, even surpassing Alzheimer's disease and diabetes. 17.9 million people in the world

Amelioration of Myocardial I/R Injury with NR via Autophagy and Oxidative Stress

2024年4月11日

オートファジーと酸化ストレスによるNRによる心筋I/R障害の改善

Introduction Myocardial ischemia-reperfusion (I/R) injury has emerged as an urgent clinical issue that may offset the benefits of reperfusion therapy and even worsen the prognosis of acute myocardial infarction, a

Quantification NAD+ and its Metabolites in Mouse Sciatic Nerves

2024年4月10日

マウス坐骨神経におけるNAD +とその代謝産物の定量化

.two-side{ text-align: justify; display: flex; justify-content: space-between; } Introduction The crucial parts of nicotinamide adenine dinucleotide (NAD+) and its metabolites in aging a

Looking for Your Arrival at Booth No 6.1 S17 in the 89th CMEF

2024年4月9日

第89回CMEFのブース番号6.1 S17へのお越しをお待ちしています

On April 11th~14th 2024, the 89th China International Medical Equipment Fair (CMEF) is going to be held at National Exhibition and Convention Center in Shanghai. Here is a feast of medicine and in vitro d

A Novel Way Out of the Dilemma in the Treatment of Breast Cancer: Rh2-Lipo

2024年4月8日

乳癌の処置のジレンマからの新しい方法:Rh2-Lipo

Introduction Ginsenoside Rh2 nanoliposome formulation has been proved to effectively target and deliver drugs to the tumor site, with less side effects and higher treatment efficiency, holding great promise in the

Beneficial Effect of NMN on the Maintenance of Neuritic Arbor in Motor Neurons

2024年4月3日

運動ニューロンにおける中性扁平の維持に対するNMNの有益な効果

Introduction Replenishing nicotinamide mononucleotide (NMN) to raise the availability of nicotinamide adenine dinucleotide (NAD+) has been deemed as effective approach to prevent neurodegeneration in aging and pat

すべての記事

健康食品EXPO・原料・受託製造2024が近づいてきました

緑内障の潜在的な治療法:NAD +前駆体NR

NMN補充によるTOCP誘発性卵母細胞損傷の軽減

NADP+/NADPHバランスと心血管疾患の密接な関係

オートファジーと酸化ストレスによるNRによる心筋I/R障害の改善

マウス坐骨神経におけるNAD +とその代謝産物の定量化

第89回CMEFのブース番号6.1 S17へのお越しをお待ちしています

乳癌の処置のジレンマからの新しい方法:Rh2-Lipo

運動ニューロンにおける中性扁平の維持に対するNMNの有益な効果

クイック照会テスト

あなたのメッセージ